Mark Clemons

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

Karen A. Gelmon, Marc Tischkowitz, Helen Mackay et al. · The Lancet Oncology · 2011 · 1.1K citations

Medicine, Gynecology, Oncology +17

Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design

Farrah Kassam, Katherine Enright, Rebecca Dent et al. · Clinical Breast Cancer · 2009 · 472 citations

Medicine, Oncology, Breast Oncology +16

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Nadine Tchen, Helen G. Juffs, Fiona Downie et al. · Journal of Clinical Oncology · 2003 · 378 citations

Medicine, Oncology, Cancer Control +9

Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer

Pamela J. Goodwin, Kathleen I. Pritchard, Marguerite Ennis et al. · Clinical Breast Cancer · 2008 · 228 citations

Medicine, Endocrinology, Oncology +9

A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer

Helen G. Mar Fan, Mark Clemons, Wei Xu et al. · Supportive Care in Cancer · 2007 · 193 citations

Medicine, Oncology, Pharmacotherapy +15